possible higher risk of blood clots with drospirenone OCs or the Evra contraceptive patch

Please see the FDA's updated information about the risk of blood clots in women taking birth control pills containing drospirenone

Women are asking about a possible higher risk of blood clots with drospirenone OCs or the Evra contraceptive patch.

They're hearing that drospirenone OCs (Yasmin, Yaz) have a 74% higher risk of thrombosis compared to other low-dose OCs.

But the absolute risk is still very small.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote